Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7736495

Concept As at
2017-06-30
2017-04-01 to
2017-06-30
2017-01-01 to
2017-06-30
2016-01-01 to
2016-12-31
As at
2016-12-31
As at
2016-06-30
2016-01-01 to
2016-06-30
2016-04-01 to
2016-06-30
Key financial data of group
Business results of group
Net sales
326,799,000 JPY
811,598,000 JPY
442,708,000 JPY
Ordinary profit (loss)
-297,318,000 JPY
-440,657,000 JPY
-208,526,000 JPY
Profit (loss) attributable to owners of parent
-316,142,000 JPY
-289,940,000 JPY
-33,752,000 JPY
Comprehensive income
-318,229,000 JPY
-406,060,000 JPY
-156,515,000 JPY
Net assets
1,491,215,000 JPY
1,739,321,000 JPY
1,983,629,000 JPY
Total assets
2,193,269,000 JPY
2,566,295,000 JPY
2,629,056,000 JPY
Basic earnings (loss) per share
-21.21
-34.03
-31.64
-3.71
-2.42
Diluted earnings per share
Equity-to-asset ratio
0.678 xbrli:pure
0.676 xbrli:pure
0.753 xbrli:pure
Net cash provided by (used in) operating activities
-222,568,000 JPY
-452,967,000 JPY
-164,107,000 JPY
Net cash provided by (used in) investing activities
-28,738,000 JPY
248,004,000 JPY
254,628,000 JPY
Net cash provided by (used in) financing activities
-15,582,000 JPY
754,897,000 JPY
625,025,000 JPY
Cash and cash equivalents
1,892,419,000 JPY
2,161,186,000 JPY
2,320,738,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.